J&J Nears Vaccine Licensing Deal with S.Africa’s Aspen

By tdpel

Published: February 24, 2022 | 11:57 AM GMT

drugmaker Johnson & Johnson, JNJ.

N, is close to a vaccine licensing deal with South African group Aspen Pharmacare, APNJ.

J, a senior J&J executive told a conference in Nigeria.

“We are at the advanced stages of a potential licensing agreement with Aspen and we are really hopeful it will be finalised,” J&J’s Vice President Global Public Health, Operations and Partnerships, Stacy Meyer said.

She gave no further details.

In November, Aspen signed non-binding terms with subsidiaries of J&J, saying this was a step towards a licensing deal for Aspen to package and sell J&J’s’s COVID-19 vaccine in Africa.

The non-binding agreements were hailed by the World Health Organization as a “transformative moment” in the drive towards greater vaccine equity.

Africa is the least vaccinated part of the world.

Multiple organisations and companies are involved in initiatives to build up vaccine manufacturing capacity on the continent, to “avoid a repeat of what happened at the start of the COVID-19 vaccination drive, when rich countries hoarded supplies.

”

Reuters/Shakirat Sadiq
J&J Nears Vaccine Licensing Deal with S.

Africa’s Aspen

Breaking News

»TDPel Media News« »For Breaking News«| »For Featured«| »For Biographies« »For Lifestyle« »For Lottery« »For Fashion« »For Politics« »For Business« »For Entertainment« »For Wellness and Fitness« »For Religion« »For Science« »For Sports« »For Technology« »For Health« »For TDPelTV« »For World News« »TDPel Media News« »For TDPel Community« »TDPel Media News« »For Breaking News«| »For Featured«| »For Biographies« »For Lifestyle« »For Lottery« »For Fashion« »For Politics« »For Business« »For Entertainment« »For Wellness and Fitness« »For Religion« »For Science« »For Sports« »For Technology« »For Health« »For TDPelTV« »For World News« »TDPel Media News« »For TDPel Community«

About tdpel

Pelumi Emmanuel is an accomplished writer and journalist with over 15 years of experience in the industry. He is a passionate and dedicated professional who is committed to producing high-quality content that informs, engages, and entertains readers. Pelumi’s love for reading and writing is evident in his work, which has been read worldwide and has garnered him a loyal following. His journalistic expertise is matched only by his natural talent for storytelling, making his articles both informative and engaging. He lives in California, USA.